Bilgin Emrecan
Research Subjects
Bilgin Emrecan has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Ali Gürbüz
7 shared publicationsCengiz Özbek
Hospital de Treinamento e Pesquisa de Ízmir Atatürk, Ìzmir, Turquia
5 shared publications- Ali Vefa Ozcan
Department of Cardiovascular Surgery, Pamukkale University, Denizli, Turkey
4 shared publications Levent Yilik
Hospital de Treinamento e Pesquisa de Ízmir Atatürk, Ìzmir, Turquia
4 shared publicationsAhmet Coşkun Özdemir
3 shared publicationsGokhan Onem
Department of Cardiac and Vascular Surgery Pamukkale University Denizli Turkey
3 shared publications
Latest Publications
- Open Access
- 28 June 2024
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 33 (2) , 112-4
Incidentally detected asymptomatic splenic artery aneurysm
Splenic artery aneurysm (SpAA) is the most common among visceral artery aneurysms and accounts for approximately 60% of visceral artery aneurysms. Generally, 80% of cases with SpAA are asymptomatic. The most common symptoms are abdominal pain, nausea and intra-abdominal bleeding due to aneurysm rupture, hypotension and hemorrhagic shock. The most serious complication is aneurysm rupture and related complications. The most useful method for diagnosis is abdominal CT angiographic imaging. The treatment is mostly surgical, but in appropriate cases, endovascular intervention can also be applied. Medical follow-up can be performed in true splenic artery aneurysms less than 2 cm in diameter. In this article, we wanted to present a fifty-two-year-old female patient with an asymptomatic splenic artery aneurysm that was detected incidentally.
- 28 June 2024
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 33 (2) , 112-4
Open AccessIncidentally detected asymptomatic splenic artery aneurysm
Splenic artery aneurysm (SpAA) is the most common among visceral artery aneurysms and accounts for approximately 60% of visceral artery aneurysms. Generally, 80% of cases with SpAA are asymptomatic. The most common symptoms are abdominal pain, nausea and intra-abdominal bleeding due to aneurysm rupture, hypotension and hemorrhagic shock. The most serious complication is aneurysm rupture and related complications. The most useful method for diagnosis is abdominal CT angiographic imaging. The treatment is mostly surgical, but in appropriate cases, endovascular intervention can also be applied. Medical follow-up can be performed in true splenic artery aneurysms less than 2 cm in diameter. In this article, we wanted to present a fifty-two-year-old female patient with an asymptomatic splenic artery aneurysm that was detected incidentally.
- Open Access
- 18 October 2023
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 32 (3) , 181-3
Right subclavian artery true aneurysm: A rare cause of dyspnea
Subclavian artery aneurysm (SAA) is a rare condition seen in less than 1% of peripheral artery aneurysms. It is usually asymptomatic. However, it may become symptomatic as a result of pressure on the surrounding organs due to the progressive growth of the aneurysm. The standard treatment for SAA is surgery. In this article, we wanted to present a 63-year-old male patient who presented with the complaint of shortness of breath and was operated on with the diagnosis of Right Subclavian artery true aneurysm on thoracic CT angiography.
- 18 October 2023
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 32 (3) , 181-3
Open AccessRight subclavian artery true aneurysm: A rare cause of dyspnea
Subclavian artery aneurysm (SAA) is a rare condition seen in less than 1% of peripheral artery aneurysms. It is usually asymptomatic. However, it may become symptomatic as a result of pressure on the surrounding organs due to the progressive growth of the aneurysm. The standard treatment for SAA is surgery. In this article, we wanted to present a 63-year-old male patient who presented with the complaint of shortness of breath and was operated on with the diagnosis of Right Subclavian artery true aneurysm on thoracic CT angiography.
- 19 April 2021
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 21 (1) , 56-66
The effects of showering in 48–72 h after coronary artery bypass graft surgery through median sternotomy on wound infection, pain, comfort, and satisfaction: randomized controlled trial
Time of showering after surgery is still a controversial issue for surgical patients and health professionals. We evaluated the effects of showering in 48–72 h after median sternotomy on sternal wound infections, pain due to sternotomy, patient comfort, and satisfaction levels. The study was a randomized controlled clinical trial. Fifty-one patients were randomly allocated (1:1) to the shower (n = 26) or non-shower group (n = 25). The patients in the shower group (intervention group) showered in the first 48–72 h after surgery and the patients in the non-shower group (control group) were not allowed to shower until their chest tube sutures were removed. They were instructed to shower on the next day after removal of the chest tube sutures. The rate of sternal wound infections was significantly lower in the shower group (n = 2, 7.7%) than in the non-shower group patients (n = 8, 32.0%; P = 0.038). A logistic regression analysis showed that early post-operative showering was protective and significantly reduced the risk of sternal wound infections independently of other variables [odds ratio (OR): 0.177; 95% confidence interval (CI): 0.033–0.940; P = 0.042]. The pain severity score was significantly lower in the shower group patients. Also, comfort and satisfaction scores were significantly higher in this group (P < 0.05). Early showering after sternotomy was found to be protective against sternal wound infections and had a positive effect on pain, comfort, and satisfaction. Clinical Trials.gov registration number NCT04250961 (https://clinicaltrials.gov/ct2/show/NCT04250961).
- 19 April 2021
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
- Vol. 21 (1) , 56-66
The effects of showering in 48–72 h after coronary artery bypass graft surgery through median sternotomy on wound infection, pain, comfort, and satisfaction: randomized controlled trial
Time of showering after surgery is still a controversial issue for surgical patients and health professionals. We evaluated the effects of showering in 48–72 h after median sternotomy on sternal wound infections, pain due to sternotomy, patient comfort, and satisfaction levels. The study was a randomized controlled clinical trial. Fifty-one patients were randomly allocated (1:1) to the shower (n = 26) or non-shower group (n = 25). The patients in the shower group (intervention group) showered in the first 48–72 h after surgery and the patients in the non-shower group (control group) were not allowed to shower until their chest tube sutures were removed. They were instructed to shower on the next day after removal of the chest tube sutures. The rate of sternal wound infections was significantly lower in the shower group (n = 2, 7.7%) than in the non-shower group patients (n = 8, 32.0%; P = 0.038). A logistic regression analysis showed that early post-operative showering was protective and significantly reduced the risk of sternal wound infections independently of other variables [odds ratio (OR): 0.177; 95% confidence interval (CI): 0.033–0.940; P = 0.042]. The pain severity score was significantly lower in the shower group patients. Also, comfort and satisfaction scores were significantly higher in this group (P < 0.05). Early showering after sternotomy was found to be protective against sternal wound infections and had a positive effect on pain, comfort, and satisfaction. Clinical Trials.gov registration number NCT04250961 (https://clinicaltrials.gov/ct2/show/NCT04250961).
- 23 December 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (2) , 680-686
Unilateral or bilateral cerebral perfusion in hemiarch replacement: A prospective randomized study
Background We designed a prospective randomized clinical study to compare unilateral and bilateral antegrade cerebral perfusion (ACP) under moderate hypethermia in open distal aortic hemiarch replacement in ascending aortic aneurysm. Methods Forty‐two patients were prospectively randomized into two groups; unilateral ACP to Group 1 and bilateral ACP to Group 2. Inclusion criteria were pathological aortic aneurysm in the ascending aorta and/or aortic arch, elective operation, normal preoperative carotid Doppler ultrasonography, and nonexistence of preoperative neurological event. Patients were evaluated with preoperative and postoperative biochemical blood analysis, magnetic resonance imaging (MRI), and neurological disorders. The primary endpoints were permanent neurological disorder and death. Results There were 21 patients in each group. Mean age was 56.57 ± 10.06 years in Group 1 and 50.95 ± 15.64 years in Group 2 (p = .170). No significant difference was found according to demographic data. ACP times were significantly higher in bilateral ACP (Group 1: 12.62 ± 5.04 min, Group 2: 18.23 ± 9.04 min, p = .018) whereas cross‐clamp time and cardiopulmonary bypass times were not (p = .693 and p = .584 sequentially). Transient neurological disorder was found in seven patients in Group 1 and in 4 patients in Group 2 (p = .484). Postoperative MRI revealed new milimetric ischemic zones in three patients in Group 1 but none in Group 2. No permanent neurological disorder or mortality was seen. Conclusion The present randomized clinical prospective study could not prove the superiority of one of the technique in cerebral protection probably because, our overall ACP time was too short.
- 23 December 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (2) , 680-686
Unilateral or bilateral cerebral perfusion in hemiarch replacement: A prospective randomized study
Background We designed a prospective randomized clinical study to compare unilateral and bilateral antegrade cerebral perfusion (ACP) under moderate hypethermia in open distal aortic hemiarch replacement in ascending aortic aneurysm. Methods Forty‐two patients were prospectively randomized into two groups; unilateral ACP to Group 1 and bilateral ACP to Group 2. Inclusion criteria were pathological aortic aneurysm in the ascending aorta and/or aortic arch, elective operation, normal preoperative carotid Doppler ultrasonography, and nonexistence of preoperative neurological event. Patients were evaluated with preoperative and postoperative biochemical blood analysis, magnetic resonance imaging (MRI), and neurological disorders. The primary endpoints were permanent neurological disorder and death. Results There were 21 patients in each group. Mean age was 56.57 ± 10.06 years in Group 1 and 50.95 ± 15.64 years in Group 2 (p = .170). No significant difference was found according to demographic data. ACP times were significantly higher in bilateral ACP (Group 1: 12.62 ± 5.04 min, Group 2: 18.23 ± 9.04 min, p = .018) whereas cross‐clamp time and cardiopulmonary bypass times were not (p = .693 and p = .584 sequentially). Transient neurological disorder was found in seven patients in Group 1 and in 4 patients in Group 2 (p = .484). Postoperative MRI revealed new milimetric ischemic zones in three patients in Group 1 but none in Group 2. No permanent neurological disorder or mortality was seen. Conclusion The present randomized clinical prospective study could not prove the superiority of one of the technique in cerebral protection probably because, our overall ACP time was too short.
- 3 May 2019
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 27 (2) , 159-164
Prosthetic valve endocarditis: A challenging complication of prosthetic valves
Background: This study aims to evaluate the surgical outcomes of prosthetic valve endocarditis. Methods: A total of 21 patients (6 males, 15 females; mean age 58.9±12.6 years; range, 33 to 79 years) who were surgically treated for prosthetic valve endocarditis between January 2013 and January 2018 were retrospectively analyzed. Surgical indications included persistent fever for more than seven days after antibiotherapy, congestive heart failure refractory to medical treatment, vegetations larger than 1 cm on echocardiography, the presence of fungal endocarditis, severe valvular leak and valvular dysfunction, and staphylococcal prosthetic valve endocarditis. Results: Five patients had previous aortic valve replacement and three of the aortic prostheses were re-replaced. Two patients had coexisting native mitral valve endocarditis and double valve replacement was done. Thirteen patients had previous mitral valve replacement and 12 of the mitral prostheses were re-replaced. One patient had coexisting native aortic valve endocarditis and double valve re-replacement was done. Three patients had previous aortic valve replacement + mitral valve replacement. Mitral valve endocarditis was diagnosed in two patients and these patients had only mitral valve re-replacement. The other patient had double valve endocarditis, and double valve replacement was done. The mean time from the first operation to the development of endocarditis was 7.3±5.7 years. Of five lost patients, two died from multiple organ failure, one from low cardiac output, one from pneumonia, and one from respiratory failure. Conclusion: Radical resection of the infected tissues is critical to achieve favorable surgical outcomes. Single valve replacement of the infected valve may be preferred in patients having previous double valve replacement. Mechanical valves or bioprostheses can be used for re-replacement procedures.
- 3 May 2019
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 27 (2) , 159-164
Prosthetic valve endocarditis: A challenging complication of prosthetic valves
Background: This study aims to evaluate the surgical outcomes of prosthetic valve endocarditis. Methods: A total of 21 patients (6 males, 15 females; mean age 58.9±12.6 years; range, 33 to 79 years) who were surgically treated for prosthetic valve endocarditis between January 2013 and January 2018 were retrospectively analyzed. Surgical indications included persistent fever for more than seven days after antibiotherapy, congestive heart failure refractory to medical treatment, vegetations larger than 1 cm on echocardiography, the presence of fungal endocarditis, severe valvular leak and valvular dysfunction, and staphylococcal prosthetic valve endocarditis. Results: Five patients had previous aortic valve replacement and three of the aortic prostheses were re-replaced. Two patients had coexisting native mitral valve endocarditis and double valve replacement was done. Thirteen patients had previous mitral valve replacement and 12 of the mitral prostheses were re-replaced. One patient had coexisting native aortic valve endocarditis and double valve re-replacement was done. Three patients had previous aortic valve replacement + mitral valve replacement. Mitral valve endocarditis was diagnosed in two patients and these patients had only mitral valve re-replacement. The other patient had double valve endocarditis, and double valve replacement was done. The mean time from the first operation to the development of endocarditis was 7.3±5.7 years. Of five lost patients, two died from multiple organ failure, one from low cardiac output, one from pneumonia, and one from respiratory failure. Conclusion: Radical resection of the infected tissues is critical to achieve favorable surgical outcomes. Single valve replacement of the infected valve may be preferred in patients having previous double valve replacement. Mechanical valves or bioprostheses can be used for re-replacement procedures.
- Open Access
- 1 February 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 37 (2) , 209-210
An extremely rare but considerably important device-related complication of percutaneous atrial septal defect closure
- 1 February 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 37 (2) , 209-210
Open AccessAn extremely rare but considerably important device-related complication of percutaneous atrial septal defect closure
- Open Access
- 1 January 2018
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 21 (2) , E4-E4a
Vibrating Heart
- 1 January 2018
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 21 (2) , E4-E4a
Open AccessVibrating Heart
- 1 October 2017
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 44, 422.e15-422.e17
Surgically Treated Pelvic Pain Caused by Nutcracker Syndrome and Worsened by Cockett Syndrome in a Child
- 1 October 2017
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 44, 422.e15-422.e17
Surgically Treated Pelvic Pain Caused by Nutcracker Syndrome and Worsened by Cockett Syndrome in a Child
- 1 January 2016
- Published by Turkiye Klinikleri in Turkiye Klinikleri Cardiovascular Sciences
- Vol. 28 (1) , 39-42
An Extensive Calcified Left Ventricular Aneurysm: Case Report
- 1 January 2016
- Published by Turkiye Klinikleri in Turkiye Klinikleri Cardiovascular Sciences
- Vol. 28 (1) , 39-42
An Extensive Calcified Left Ventricular Aneurysm: Case Report
- 1 October 2015
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 23 (4) , 672-677
Paramedian retroperitoneal approach for revascularization of aortoiliac occlusive disease
- 1 October 2015
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 23 (4) , 672-677
Paramedian retroperitoneal approach for revascularization of aortoiliac occlusive disease